CSL Behring sp. z o.o. secures contract for Pharmaceutical products Supply of human normal immunoglobulins for the treatment of secondary immunodeficiencies immune-related diseases albumins divided into 16 parts DZPUCK2620022026

Poland, April 27 -- Poland based CSL Behring sp. z o.o. has secured contract from Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego for Pharmaceutical products Supply of human normal immunoglobulins for the treatment of secondary immunodeficiencies immune-related diseases albumins divided into 16 parts DZPUCK2620022026. The value of the contract is worth 448020000 PLN.

Published by HT Digital Content Services with permission from Pivotal Sources....